Skip to main content
. 2010 May-Jun;17(3):245–252. doi: 10.1136/jamia.2009.000182

Table 2.

System performance and expert evaluation on the test set

Unstable angina/non-ST-segment elevation myocardial infarction True positive False positive False negative True negative Total Overall accuracy κ Value Sensitivity Specificity Positive predictive value Negative predictive value Attainment rate by system Attainment rate by gold standards
Measure 1 Early invasive approach by coronary angioplasty 264 33 78 252 627 0.823 0.65 0.77 0.88 0.889 0.76 0.48 0.55
Measure 3 ACE inhibitors/angiotensin receptor blockers before discharge (poor left ventricular ejection fraction) 48 1 2 22 73 0.958 0.91 0.96 0.96 0.980 0.92 0.67 0.68
Measure 4 Aspirin before discharge 474 2 5 24 505 0.986 0.87 0.99 0.92 0.996 0.83 0.94 0.95
Measure 5 β-blockers before discharge 296 1 6 185 488 0.986 0.97 0.98 0.99 0.997 0.97 0.61 0.62
Measure 6 Statin before discharge 167 0 7 340 514 0.986 0.97 0.96 1.00 1.000 0.98 0.32 0.34

Measures 7 and 8 are reported in the text.